Molecular Partners AG is a clinical-stage biotech company pioneering the design and development of DARPin therapeutics for medical challenges other drug modalities cannot readily address. The ...

Sunday April 27 at 2:00pm - 5:00pm CST Location: Poster Section 16, Poster Board Number: 13 Molecular Partners NewsMORE Related Stocks ...

March 25, 2025 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX ... or the“Company”), today announced it will hold three poster presentations at the American Association for Cancer Research ...

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 25, 2025 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of ...